A proteomic analysis of differentiating dopamine neurons derived from human embryonic stem cells

다국어 초록 (Multilingual Abstract)

Human embryonic stem cells (hESC) are being exploited for potential use in cell transplantation due to their capacity for self-renewal and pluripotency. Dopamine (DA) neurons derived from hESC represent a promising source of cell replacement therapy for Parkinson’s disease (PD). While gene expression on the transcriptome level has been extensively studied, limited information is available for the proteome-level changes associated with DA neuron differentiation. Here we analyzed the proteome of differentiating DA neurons to search for the potential biomarkers to assess the efficiency of differentiation. Although the proteome profile of DA neurons did not exhibit significant changes, a number of cytoskeletal proteins including nuclear lamin, tropomyosin 1, and myosin light chain 1 were specifically up-regulated during differentiation.
Expression analysis of the respective genes was also consistent with the proteome results. In addition, these differentially expressed proteins form protein interaction network with several PD-related proteins suggesting that they may play roles in PD pathogenesis as well as the maturation of DA neurons.

참고문헌 (Reference)

1 Weiss B, "Wree A, Schmitt O. 2014. The proteome of the differentiating mesencephalic progenitor cell line CSM14.1 in vitro" 2014 : 351821-, 2014

2 Curthoys NM, "Tropomyosins induce neuritogenesis and determine neurite branching patterns in B35 neuroblastoma cells" 58 : 11-21, 2014

3 Xia N, "Transcriptional comparison of human induced and primary midbrain dopaminergic neurons" 6 : 20270-, 2016

4 Martin I, "Ribosomal protein s15 phosphorylation mediates LRRK2 neurodegeneration in Parkinson’s disease" 157 : 472-485, 2014

5 Fathi A, "Quantitative proteomics analysis highlights the role of redox hemostasis and energy metabolism in human embryonic stem cell differentiation to neural cells" 101 : 1-16, 2014

6 Rhee YH, "Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson disease" 121 : 2326-2335, 2011

7 Zanon A, "Profiling of parkin-binding partners using tandem affinity purification" 8 : e78648-, 2013

8 Kirkeby A, "Predictive markers guide differentiation to improve graft outcome in clinical translation of hESC-based therapy for Parkinson’s disease" 20 : 135-148, 2017

9 Sonntag KC, "Pluripotent stem cell-based therapy for Parkinson’s disease : current status and future prospects" 168 : 1-20, 2018

10 Lim MS, "Noggin over-expressing mouse embryonic fibroblasts and MS5 stromal cells enhance directed differentiation of dopaminergic neurons from human embryonic stem cells" 10 : e0138460-, 2015

11 Häbig K, "LRRK2 guides the actin cytoskeleton at growth cones together with ARHGEF7 and Tropomyosin 4" 1832 : 2352-2367, 2013

12 Park CH, "In vitro and in vivo analyses of human embryonic stem cell-derived dopamine neurons" 92 : 1265-1276, 2005

13 Hill-Burns EM, "Identification of genetic modifiers of age-at-onset for familial Parkinson’s disease" 25 : 3849-3862, 2016

14 Ganat YM, "Identification of embryonic stem cell-derived midbrain dopaminergic neurons for engraftment" 122 : 2928-2939, 2012

15 Tachibana M, "Human embryonic stem cells derived by somatic cell nuclear transfer" 153 : 1228-1238, 2013

16 Grealish S, "Human ESC-derived dopamine neurons show similar preclinical efficacy and potency to fetal neurons when grafted in a rat model of Parkinson’s disease" 15 : 653-665, 2014

17 Kirkeby A, "Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions" 1 : 703-714, 2012

18 Marei HE, "Gene expression profiling of embryonic human neural stem cells and dopaminergic neurons from adult human substantia nigra" 6 : e28420-, 2011

19 Yasuhara T, "Cell therapy for Parkinson’s disease" 26 : 1551-1559, 2017

20 Man JHK, "Cell reprogramming approaches in gene-and cell-based therapies for Parkinson’s disease" 286 : 114-124, 2018

21 Malty RH, "A map of human mitochondrial protein Interactions linked to neurodegeneration reveals new mechanisms of redox homeostasis and NF-κB signaling" 5 : 564-577, 2017

22 Meixner A, "A QUICK screen for Lrrk2 interaction partners – leucine-rich repeat kinase 2 is involved in actin cytoskeleton dynamics" 10 : 1-17, 2011